Alar Pharmaceuticals Inc. (6785)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
85. 70
+2.6
+3.1288%
NT$
- Market Cap
8.62 P/E Ratio
184% Div Yield
49,389 Volume
0 Eps
NT$ 83.1
Previous Close Want to track 6785 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alar Pharmaceuticals Inc. (6785) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.08B
Trailing P/E (ttm) -80.83
Forward P/E -
PEG ratio 0.71
Price/Sales (ttm) 1,961.69
Price/Book (mrq) 2.51
Enterprise Value/Revenue 1,361.65
Enterprise Value/EBITDA -39.41
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 61.77K
Average volume (90 days) 62.95K
Price summary
52-Week low 81.1
52-Week high 317
Beta -
50-Day moving average 95.31
200-Day moving average 120.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.1
Trailing annual dividend yield 0.0011%
5-Year annual dividend yield -
Payout ratio -0.23
Dividend Date 14 Sep 2026
Ex-Dividend Date 25 Aug 2026
Last split factor 2:1
Last split Date 26 Jun 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -24.04%
Operating margin -57.08%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 33.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 38.77%
Book value per share (mrq) 35.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
